소규모 바이오리액터 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용량별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Small-scale Bioreactors Market Growth & Trends:

The global small-scale bioreactors market size is estimated to reach USD 2.49 billion by 2033, registering a CAGR of 9.4% from 2025 to 2033, according to a new report by Grand View Research, Inc. The product has a high demand and the market is anticipated to grow rapidly as a result of the COVID-19 pandemic. The pandemic has increased the need for research on cell-based drug discovery and also the demand for manufacturing novel medicines and vaccines according to the size of the population. For instance, according to the World Health Organization's 2022 report, vaccine research has accelerated to an unprecedented pace in response to the COVID-19 pandemic and approximately 11.25 billion vaccine doses had been given around the globe as of 4 April 2022.

Moreover, the use of small-scale bioprocessing systems in upstream processing, parallel processing, and experiment evaluation for bioprocess optimization is expected to drive the demand for small-scale bioreactors in process development. Revenues in the bioprocessing technology industry have increased as a result of COVID-19. Thus, the development of a SARS-CoV-2 vaccine has progressed quickly, according to all major suppliers. In addition, the demand for bioprocessing technologies had also grown as a result of a rise in vaccine R&D. For instance, in July 2020, Danaher, the parent company of Pall and Cytiva, reported a 26% increase in net income and a 19% increase in second-quarter sales. Similarly, Sartorius Stedim Biotech also has benefited from the pandemic. The company's sales increased 18% to $1.05 billion in the first half of the year.

The desire for COVID-19 was cited by company executives as a key driver. Furthermore, the strong demand for small-scale bioreactors is being driven by the recent increase in COVID-19-related research and development between several biotech and pharmaceutical companies. Furthermore, the growth of the market during the forecast period is fueled by the rise in technical development and advancements in equipment design for bioprocessing. The sales of small-scale bioreactors are also expected to increase as a result of an increase in product launches and the expansion of product lines by several manufacturers. For instance, in October 2022, Froilabo expanded its line of temperature-controlled laboratory equipment by introducing a new collection of completely automated lab-scale bioprocessing systems.

Small-scale Bioreactors Market Report Highlights:

• Based on product, the reusable bioreactors segment is expected to grow significantly during the forecast period, owing to the higher need for reusable bioreactors in the pharmaceutical and biopharmaceutical industries for cost-effective manufacturing.
• The 1L-3L capacity segment accounted for the largest revenue share in 2024, due to the wide-scale availability of bioreactors with a working volume capacity of 1L-3L in small-scale production.
• The CROs & CMOs end-user segment held the largest share in 2024. Since these companies have adopted novel single-use bioreactors much more quickly than therapeutic manufacturers, they have contributed to a larger revenue share.
• North America was the dominant regional market in 2024, due to the presence of several global players and growing investments from public & private organizations for proteomic and life science research in the region.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Segment Definitions
    • 1.1.1.1. Product
    • 1.1.1.2. Capacity
    • 1.1.1.3. End Use
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information or Data Analysis:
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity Flow Analysis
• 1.7. List of Secondary Sources
• 1.8. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Increasing research & development activities in the biopharmaceutical industry
    • 3.3.1.2. Highly competitive market and various strategies undertaken by market players
    • 3.3.1.3. Increasing demand for single-use small-scale bioreactors
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Limitations of small-scale bioreactors
• 3.4. Industry Analysis Tools
  • 3.4.1. SWOT Analysis: By Factor (Political & Legal, Economic, And Technological)
  • 3.4.2. Porter's Five Forces Analysis

Chapter 4. Small-Scale Bioreactors Market: Product Business Analysis

• 4.1. Small-Scale Bioreactors Market: Product Market Share Analysis
• 4.2. Small-Scale Bioreactors Market Estimates & Forecast, By Product (USD Million)
• 4.3. Reusable Bioreactors
  • 4.3.1. Global Reusable Bioreactors Market, 2021 - 2033 (USD Million)
  • 4.3.2. Stainless Steel Bioreactors
    • 4.3.2.1. Global Stainless Steel Bioreactors Market, 2021 - 2033 (USD Million)
  • 4.3.3. Glass Bioreactors
    • 4.3.3.1. Global Glass Bioreactors Market, 2021 - 2033 (USD Million)
• 4.4. Single-use Bioreactors
  • 4.4.1. Global Single-use Bioreactors Market, 2021 - 2033 (USD Million)

Chapter 5. Small-Scale Bioreactors Market: Capacity Business Analysis

• 5.1. Small-Scale Bioreactors Market: Capacity Market Share Analysis
• 5.2. Small-Scale Bioreactors Market Estimates & Forecast, By Capacity (USD Million)
• 5.3. 5 ML- 100 ML
  • 5.3.1. Global 5 ML - 100 ML Market, 2021 - 2033 (USD Million)
• 5.4. 100 ML - 250 ML
  • 5.4.1. Global 100 ML - 250 ML Market, 2021 - 2033 (USD Million)
• 5.5. 250 ML - 500 ML
  • 5.5.1. Global 250 ML - 500 ML Market, 2021 - 2033 (USD Million)
• 5.6. 500 ML - 1 L
  • 5.6.1. Global 500 ML - 1 L Market, 2021 - 2033 (USD Million)
• 5.7. 1 L - 3 L
  • 5.7.1. Global 1 L - 3 L Market, 2021 - 2033 (USD Million)
• 5.8. 3 L - 5 L
  • 5.8.1. Global 3 L - 5 L Market, 2021 - 2033 (USD Million)

Chapter 6. Small-Scale Bioreactors Market: End Use Business Analysis

• 6.1. Small-Scale Bioreactors Market: End Use Market Share Analysis
• 6.2. Small-Scale Bioreactors Market Estimates & Forecast, By End Use (USD Million)
• 6.3. Pharmaceutical & Biopharmaceutical Companies
  • 6.3.1. Global Pharmaceutical & Biopharmaceutical Companies Market, 2021 - 2033 (USD Million)
• 6.4. CROs & CMOs
  • 6.4.1. Global CROs & CMOs Market, 2021 - 2033 (USD Million)
• 6.5. Academic & Research Institutes
  • 6.5.1. Global Academic & Research Institutes Market, 2021 - 2033 (USD Million)

Chapter 7. Small-Scale Bioreactors Market: Regional Business Analysis

• 7.1. Small-Scale Bioreactors Market Share By Region, 2024 & 2033
• 7.2. North America
  • 7.2.1. North America Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.2.2. U.S.
    • 7.2.2.1. Key Country Dynamics
    • 7.2.2.2. Competitive Scenario
    • 7.2.2.3. Regulatory Framework
    • 7.2.2.4. U.S. Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.2.3. Canada
    • 7.2.3.1. Key Country Dynamics
    • 7.2.3.2. Competitive Scenario
    • 7.2.3.3. Regulatory Framework
    • 7.2.3.4. Canada Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.2.4. Mexico
    • 7.2.4.1. Key Country Dynamics
    • 7.2.4.2. Competitive Scenario
    • 7.2.4.3. Regulatory Framework
    • 7.2.4.4. Mexico Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
• 7.3. Europe
  • 7.3.1. Europe Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.3.2. UK
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. UK Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.3.3. Germany
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Germany Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.3.4. France
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Framework
    • 7.3.4.4. France Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.3.5. Italy
    • 7.3.5.1. Key Country Dynamics
    • 7.3.5.2. Competitive Scenario
    • 7.3.5.3. Regulatory Framework
    • 7.3.5.4. Italy Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.3.6. Spain
    • 7.3.6.1. Key Country Dynamics
    • 7.3.6.2. Competitive Scenario
    • 7.3.6.3. Regulatory Framework
    • 7.3.6.4. Spain Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.3.7. Denmark
    • 7.3.7.1. Key Country Dynamics
    • 7.3.7.2. Competitive Scenario
    • 7.3.7.3. Regulatory Framework
    • 7.3.7.4. Denmark Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.3.8. Sweden
    • 7.3.8.1. Key Country Dynamics
    • 7.3.8.2. Competitive Scenario
    • 7.3.8.3. Regulatory Framework
    • 7.3.8.4. Sweden Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.3.9. Norway
    • 7.3.9.1. Key Country Dynamics
    • 7.3.9.2. Competitive Scenario
    • 7.3.9.3. Regulatory Framework
    • 7.3.9.4. Norway Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Asia Pacific Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.2. Japan
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. Japan Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.3. China
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. China Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.4. India
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. India Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.5. Australia
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Framework
    • 7.4.5.4. Australia Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.6. Thailand
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Framework
    • 7.4.6.4. Thailand Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.7. South Korea
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Framework
    • 7.4.7.4. South Korea Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
• 7.5. Latin America
  • 7.5.1. Latin America Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.5.2. Brazil
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Brazil Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.5.3. Argentina
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Argentina Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
• 7.6. MEA
  • 7.6.1. MEA Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.6.2. South Africa
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. South Africa Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.6.3. Saudi Arabia
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Saudi Arabia Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.6.4. UAE
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. UAE Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.6.5. Kuwait
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Kuwait Small-Scale Bioreactors Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Profiles/Listing
  • 8.3.1. Sartorius AG
    • 8.3.1.1. Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Product Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Thermo Fisher Scientific Inc.
    • 8.3.2.1. Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Product Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Merck KGaA
    • 8.3.3.1. Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Product Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Danaher Corporation
    • 8.3.4.1. Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Product Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. LAMBDA Instruments GmbH
    • 8.3.5.1. Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Product Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Solida Biotech GmbH
    • 8.3.6.1. Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Product Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. Getinge AB
    • 8.3.7.1. Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Product Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. DONALDSON ITALIA S.R.L (Solaris Biotechnology Srl)
    • 8.3.8.1. Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Product Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Eppendorf AG
    • 8.3.9.1. Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Product Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. Infors AG
    • 8.3.10.1. Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Product Benchmarking
    • 8.3.10.4. Strategic Initiatives